The Objective is to Compare the Efficacy and Safety of Masitinib in Combination With Riluzole in the Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS)

Condition:   Amyotrophic Lateral Sclerosis (ALS)
Interventions:   Drug: Masitinib (AB1010);   Drug: Riluzole;   Drug: Placebo
Sponsor:   AB Science
Active, not recruiting - verified July 2016
Source: 
The Objective is to Compare the Efficacy and Safety of Masitinib in Combination With Riluzole in the Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS)
News Type: 
Clinical Trials